Medical Weight Loss for Scottsbluff, Nebraska Residents
Scottsbluff, Nebraska residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Scottsbluff through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Scottsbluff Residents Choose New Hope Weight Loss
Scottsbluff patients choose New Hope Weight Loss because a named physician, Dr. Anjmun Sharma, M.D., oversees every case, pricing is transparent (semaglutide from $166/month, tirzepatide from $233/month · just $7.70/day), and the entire program runs by telehealth from our Costa Mesa, California clinic, which has served over 5,400 patients across Nebraska and beyond since 2020.
Medical weight loss for Scottsbluff is handled end-to-end online: intake, the $119 physician review with Dr. Sharma, dose titration, and follow-ups, all by secure video, with no drive and no pharmacy line.
In Scottsbluff, Nebraska, you do not need a local clinic to begin: our physician-led program reaches you by telehealth. We care for patients throughout downtown Scottsbluff and the North Platte Valley of the Nebraska Panhandle. Spanish-speaking Scottsbluff patients complete the entire program, intake, consultation, and follow-up, in Spanish with our bilingual team.
Whether you live in central Scottsbluff or its outskirts, you get exactly the same care and the same price. Compounded semaglutide and tirzepatide are not FDA-approved or brand-identical, which Dr. Sharma reviews with you before you begin.
GLP-1 Weight Loss Programs Available
Two GLP-1 programs for Scottsbluff
Compounded semaglutide starts at $166/month (a 90-day program is $499) and uses the same active ingredient as Wegovy® and Ozempic®, which produced 15-17% average body-weight loss in clinical trials. Compounded tirzepatide starts at $233/month and uses a dual GLP-1/GIP mechanism shown to reach up to 22.5% in trials.
Every plan begins with a $119 physician review. Medication is billed separately, and HSA, FSA, Klarna, and Affirm are all accepted, with no distance surcharge.
How Telehealth Works for Scottsbluff
First, you complete the online medical intake in a few minutes. Next, Dr. Sharma reviews your history by secure video, usually within 48 hours. If you are a candidate and telehealth-eligible, your compounded medication ships to your Scottsbluff address in cold-pack packaging, and follow-ups and dose adjustments continue by video, with no travel.
Frequently Asked Questions, Scottsbluff
Does New Hope Weight Loss treat patients in Scottsbluff?
Yes. Although the clinic is in Costa Mesa, California, we treat Scottsbluff, Nebraska residents by telehealth, Dr. Sharma reviews your case by secure video and compounded medication ships to your home. Eligibility is confirmed during the consultation.
Do I have to travel to get started from Scottsbluff?
No travel is needed. The whole process, intake, consultation, and follow-ups, is by secure video, and your medication arrives at your Scottsbluff address in cold-pack packaging.
What do Scottsbluff patients pay?
Flat nationwide pricing: $119 for the physician review, then semaglutide from $166/month and tirzepatide from $233/month, medication billed separately. HSA, FSA, Klarna, and Affirm are accepted, with no distance surcharge.
What areas of Scottsbluff do you serve?
We serve patients from across Scottsbluff by telehealth, including downtown Scottsbluff and the North Platte Valley of the Nebraska Panhandle.
How is medication shipped to Scottsbluff patients?
After Dr. Sharma approves your plan, compounded medication ships in discreet, temperature-appropriate packaging directly to your Scottsbluff address from the identified 503(a) compounding pharmacy. Most patients receive it within days, with no pharmacy line and no drive.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Scottsbluff, Nebraska by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.